BioSpace News Archive

Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® genome editing platform, today announced positive interim clinical results from its Phase 1/2a study of PBCAR0191, the Company’s off-the-shelf allogeneic CAR T cell therapy investigational candidate targeting CD19.

Burning Rock Biotech Limited, a company focused on the application of next generation sequencing technology in the field of precision oncology, announced the pricing of an upsized secondary public offering by certain selling shareholders of 2,243,000 American Depositary Shares, each representing one Class A ordinary share of the Company, at a public offering price of US$25.75 per ADS.

Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced it will host a live webcast providing a current corporate overview, followed by a moderated question and answer session on Monday, December 14.

Samsung Biologics announced the launch of a virtual showroom to provide key features and real-time construction updates of its recently announced Plant 4.

Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing oral integrin therapies, today announced the appointment of Dr. Martin W. Edwards, to its Board of Directors.

I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics, today announced the advancement of clinical development of the highly differentiated anti-CD47 monoclonal antibody lemzoparlimab (also known as TJC4) in the US and China, achieving milestones as planned.

Eli Lilly and Company (NYSE: LLY) and UnitedHealth Group (NYSE: UNH) today announced a partnership to conduct a pragmatic study of bamlanivimab (LY-CoV555) in high-risk, COVID-19 infected individuals.

CapsoVision, Inc., an innovator in the gastroenterology diagnostics market and manufacturer of the CapsoCam Plus® capsule endoscope, announced that it has achieved the International Standard Organization 27001 security certification.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Translarna™ (ataluren) has been granted marketing approval in the Russian Federation for nonsense mutation Duchenne muscular dystrophy (nmDMD).

Navitus Health Solutions, a full pass-through pharmacy benefit manager (PBM), announced today that it won platinum awards for Best Annual Drug Trend Report and Best Integrated Marketing Campaign from the 21 st Annual eHealthcare Leadership Awards . Announced at the healthcare internet conference’s virtual HCIC@Home conference, the eHealthcare Leadership Awards honor the best websites and digital communications from a broa